vaccination for persons with chronic liver disease (including, but notlimited to, those with hepatitis C virus [HCV] infection, cirrhosis, fattyliver disease, alcoholic liver disease, autoimmune hepatitis, and an alanineaminotransferase [ALT] or aspartate aminotransferase [AST] level greaterthan twice the upper limit of normal); and. This evidence concerns the gene GPT and alcoholic liver diseases.